Article Information
History
- August 9, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Oliver Stirrup1,*,
- Madhumita Shrotri2,
- Natalie L. Adams2,
- Maria Krutikov2,
- Hadjer Nacer-Laidi2,
- Borscha Azmi2,
- Tom Palmer1,
- Christopher Fuller2,
- Aidan Irwin-Singer3,
- Verity Baynton3,
- Gokhan Tut4,
- Paul Moss4,
- Andrew Hayward5,6,
- Andrew Copas1 and
- Laura Shallcross2,#
- 1Institute for Global Health, University College London, London, UK
- 2UCL Institute of Health Informatics, London, UK
- 3Department of Health and Social Care, London, UK
- 4Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
- 5UCL Institute of Epidemiology & Healthcare, London, UK
- 6Health Data Research UK, London, UK
Posted August 09, 2022.
Clinical effectiveness of SARS-CoV-2 booster vaccine against Omicron infection in residents and staff of Long-Term Care Facilities: a prospective cohort study (VIVALDI)
